With the rise in popularity of GLP-1 drugs for weight loss, there was a tendency to prematurely discontinue treatment due to side effects. Michael Costello, CEO of GNC, joins Wealth! to discuss how the company aims to help people taking these medications combat associated side effects.
Costello emphasizes that GNC strives to provide “a very simple way” for people using GLP-1 medications to visit their stores and gain a clear understanding of the products and supplements that can help them on their weight loss journey . He acknowledges that side effects can range from gastrointestinal issues to problems related to muscle mass and bone density.
Costello highlights the range of products GNC offers to help alleviate these side effects. It further explains the steps the company is taking to train its workforce, ensuring that they are well-equipped to guide customers effectively.
For more expert insights and the latest market action, click here to watch this full episode of Wealth!
Editor’s note: This article was written by Angel Smith
